» Articles » PMID: 37159827

TBX5 Variants Are Associated with Susceptibility to and the Incidence of Liver Cirrhosis and Hepatocellular Carcinoma in the Chinese Population: A Multicenter and Follow-Up Study

Overview
Publisher Dove Medical Press
Date 2023 May 9
PMID 37159827
Authors
Affiliations
Soon will be listed here.
Abstract

Purpose: Liver cirrhosis (LC) and hepatocellular carcinoma (HCC) are progressions affected by genetic predispositions, and persistent hepatitis B virus infection also demonstrates genetic susceptibility. All HBV-related outcomes have been compared in parallel to identify risk polymorphism in HBV progression.

Methods: The multiple-stage association study filtered and validated the risk SNPs for HBV progression and explored their association with persistent infection, with a total of 8906 subjects in China from three sites. Cox proportional hazards models and Kaplan-Meier Log rank tests were used to determine the time to the progressive event in relation to the risk SNPs.

Results: Rs3825214 in TBX5 replicated a specific association with LC and HCC in 4 progression cohorts and was not related to persistent infection, naivety to HBV infection and natural clearance in 3 persistent cohorts. In combined samples, rs3825214 was associated with an increased risk of LC (<0.001; OR = 1.98) and HCC (<0.001; OR = 1.68). The results of bioinformatics analysis indicated that rs3825214 genotypes change RNA structure and intron excision ratio. In the follow-up of 571 hospital-based persistent HBV infection patients, ninety-three (16.29%) developed LC, and seventy-four (12.96%) progressed to HCC at a median follow-up of 5.1 years. Rs3825214 was associated with HCC and LC events in Cox proportional hazards models (<0.001).

Conclusion: We identified and confirmed that genetic variants in TBX5 are significantly associated with susceptibility to and the incidence of LC and HCC.

Citing Articles

Epigenetic regulation of H3K27me3 in laying hens with fatty liver hemorrhagic syndrome induced by high-energy and low-protein diets.

Cui Y, Ru M, Wang Y, Weng L, Haji R, Liang H BMC Genomics. 2024; 25(1):374.

PMID: 38627644 PMC: 11022457. DOI: 10.1186/s12864-024-10270-w.

References
1.
Beasley R, Hwang L, Lin C, Chien C . Hepatocellular carcinoma and hepatitis B virus. A prospective study of 22 707 men in Taiwan. Lancet. 1981; 2(8256):1129-33. DOI: 10.1016/s0140-6736(81)90585-7. View

2.
Lai C, Yuen M . Chronic hepatitis B--new goals, new treatment. N Engl J Med. 2008; 359(23):2488-91. DOI: 10.1056/NEJMe0808185. View

3.
Kamatani Y, Wattanapokayakit S, Ochi H, Kawaguchi T, Takahashi A, Hosono N . A genome-wide association study identifies variants in the HLA-DP locus associated with chronic hepatitis B in Asians. Nat Genet. 2009; 41(5):591-5. DOI: 10.1038/ng.348. View

4.
Levy D, Ehret G, Rice K, Verwoert G, Launer L, Dehghan A . Genome-wide association study of blood pressure and hypertension. Nat Genet. 2009; 41(6):677-87. PMC: 2998712. DOI: 10.1038/ng.384. View

5.
Hu L, Zhai X, Liu J, Chu M, Pan S, Jiang J . Genetic variants in human leukocyte antigen/DP-DQ influence both hepatitis B virus clearance and hepatocellular carcinoma development. Hepatology. 2011; 55(5):1426-31. DOI: 10.1002/hep.24799. View